Literature DB >> 25369845

Obstetric and neonatal outcomes of pregnant women with severe mental illness at a specialist antenatal clinic.

Thinh N Nguyen1, Deb Faulkner2, Jacqueline S Frayne3, Suzanna Allen3, Yvonne L Hauck3, Daniel Rock2, Jonathan Rampono3.   

Abstract

OBJECTIVE: To evaluate the obstetric and neonatal outcomes of pregnant women with severe mental illness (SMI) who attended a specialist multidisciplinary antenatal clinic in Perth, Western Australia. DESIGN, SETTING AND PARTICIPANTS: A retrospective case-note audit of outcomes from the Childbirth and Mental Illness Antenatal Clinic (CAMI clinic) at King Edward Memorial Hospital for pregnant women with severe mental illness (SMI), aged 18-41 years, who gave birth between December 2007 and April 2011, and their babies. MAIN OUTCOME MEASURES: Obstetric and neonatal outcomes for 138 women and newborns from singleton live births. Data were compared between three diagnostic groups (schizophrenia, bipolar and non-psychotic SMI), and with WA obstetric and perinatal statistics for 2008.
RESULTS: 44 women with schizophrenia, 56 with bipolar disorder and 38 with non-psychotic SMI attended antenatal care for an average of 7.7 (SD, 3.3) visits. The proportion of women who smoked tobacco was significantly higher than that in the WA antenatal population (46% v 15%; P < 0.0001). Alcohol use, illicit substance use and psychotropic medication exposure during pregnancy were high. The women were at increased risk of developing gestational diabetes mellitus (15% v 4%; P < 0.0001) and pre-eclampsia (9% v 3%; P < 0.0001), and birth complications were more common. Babies born to CAMI clinic women were less likely to have Apgar scores ≥ 8 at 1 minute and 5 minutes. Pregnant women with schizophrenia had more psychiatric relapses during pregnancy, and had more statutory child welfare involvement. Gestational age at birth and infant birth weights were similar for the pregnant women with SMI and the WA population in 2008.
CONCLUSIONS: Women attending our specialist clinic had increased rates of obstetric and neonatal complications compared with the general population, and were exposed to a cluster of risk factors. We report encouraging trends in antenatal attendance, gestational age at birth, and birth weights. Managing pregnant women with SMI will require a comprehensive approach aimed at early detection of obstetric complications and psychosocial difficulties, as well as neonatal monitoring. Optimising prepregnancy maternal health and welfare may also be of benefit.

Entities:  

Mesh:

Year:  2013        PMID: 25369845     DOI: 10.5694/mja11.11152

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  9 in total

Review 1.  Lithium Use and Non-use for Pregnant and Postpartum Women with Bipolar Disorder.

Authors:  Alison Hermann; Alyson Gorun; Abigail Benudis
Journal:  Curr Psychiatry Rep       Date:  2019-11-07       Impact factor: 5.285

2.  Maternal schizophrenia and adverse birth outcomes: what mediates the risk?

Authors:  Simone N Vigod; Kinwah Fung; Abigail Amartey; Emily Bartsch; Reema Felemban; Natasha Saunders; Astrid Guttmann; Maria Chiu; Lucy C Barker; Paul Kurdyak; Hilary K Brown
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2019-12-06       Impact factor: 4.328

3.  Schizophrenia pregnancies should be given greater health priority in the global health agenda: results from a large-scale meta-analysis of 43,611 deliveries of women with schizophrenia and 40,948,272 controls.

Authors:  Damien Etchecopar-Etchart; Roxane Mignon; Laurent Boyer; Guillaume Fond
Journal:  Mol Psychiatry       Date:  2022-07-08       Impact factor: 13.437

4.  Bipolar disorder and psychotropic medication: Impact on pregnancy and neonatal outcomes.

Authors:  Katherine L Wisner; Dorothy Sit; Kelly O'Shea; Debra L Bogen; Crystal T Clark; Emily Pinheiro; Amy Yang; Jody D Ciolino
Journal:  J Affect Disord       Date:  2018-09-18       Impact factor: 4.839

5.  Pre-existingmental health disorders affect pregnancy and neonatal outcomes: a retrospectivecohort study.

Authors:  Kotryna Sūdžiūtė; Greta Murauskienė; Kristina Jarienė; Algirdas Jaras; Meilė Minkauskienė; Virginija Adomaitienė; Irena Nedzelskienė
Journal:  BMC Pregnancy Childbirth       Date:  2020-07-25       Impact factor: 3.007

6.  Schizophrenia and pregnancy: a national register-based follow-up study among Finnish women born between 1965 and 1980.

Authors:  Laura Simoila; Erkki Isometsä; Mika Gissler; Jaana Suvisaari; Erja Halmesmäki; Nina Lindberg
Journal:  Arch Womens Ment Health       Date:  2019-02-14       Impact factor: 3.633

7.  A study of diabetic ketoacidosis in the pregnant population in the United Kingdom: Investigating the incidence, aetiology, management and outcomes.

Authors:  Caroline Diguisto; Mark W J Strachan; David Churchill; Goher Ayman; Marian Knight
Journal:  Diabet Med       Date:  2021-11-28       Impact factor: 4.213

8.  Severe mental illness and pregnancy outcomes in Australia. A population-based study of 595 792 singleton births 2009-2016.

Authors:  Kristina Edvardsson; Elizabeth Hughes; Beverley Copnell; Ingrid Mogren; Don Vicendese; Richard Gray
Journal:  PLoS One       Date:  2022-02-28       Impact factor: 3.240

9.  Long-acting injectable aripiprazole in pregnant women with schizophrenia: a case-series report.

Authors:  Blanca Fernández-Abascal; Maria Recio-Barbero; Margarita Sáenz-Herrero; Rafael Segarra
Journal:  Ther Adv Psychopharmacol       Date:  2021-01-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.